Trademarks = 1

Forward Citations = 5

Loading Chart...

7 inventors (with patents filed for the assignee):

Anthony P Ford (8 out of 21 patents)

David Scott Carter (4 out of 15 patents)

Jiaxin Yu (3 out of 67 patents)

4. Gabriel Vargas (3 out of 3 patents)

5. Wei P Chen (2 out of 121 patents)

6. Wei Chen (2 out of 3 patents)

7. Renee S Martin (1 out of 1 patent)

8 patents: Sort by Forward Citations

1. 12723038 - α-adrenergic receptor agonists and methods of use (2026-09-01),

2. 12616667 - Compositions and methods for improving neurological diseases and disorders (2026-05-05),

3. 12558325 - Methods for improving neurological diseases and disorders (2026-02-24),

4. 12448352 - Beta adrenergic agonist and methods of using the same (2025-10-21),

5. 11607395 - Methods for improving neurological diseases and disorders (2023-03-21),

6. 11590107 - Methods for treating neurological disorders with α-AR partial agonists (2023-02-28),

7. 11040944 - Beta adrenergic agonist and methods of using the same (2021-06-22),

8. 10947196 - Beta adrenergic agonist and methods of using the same (2021-03-16),

Company Overview

Curasen Therapeutics, Inc. is a biotechnology company that focuses on developing innovative therapies for chronic illnesses. With a commitment to improving patient outcomes, Curasen specializes in the research and development of new treatment options for a variety of diseases. Their team of experts is dedicated to advancing medical science and bringing cutting-edge solutions to those in need.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

8 Patents

#99 in San Mateo, CA

#8,540 in California

#35,924 in US

San Mateo, CA, United States of America

Curasen Therapeutics, Inc.

Forward Citations = 5

7 inventors:

Anthony P Ford (8 out of 21 patents)

David Scott Carter (4 out of 15 patents)

Jiaxin Yu (3 out of 67 patents)

4. Gabriel Vargas (3 out of 3 patents)

5. Wei P Chen (2 out of 121 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Curasen Therapeutics, Inc.. Retrieved from https://idiyas.com/company/curasen-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]